Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SVASINOVAC BIOTECH LTD

Nasdaq · CIK 0001084201
Filer categoryAccelerated filer
Entity typeother
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts446

Identity from submissions API

NameSINOVAC BIOTECH LTD
CIK0001084201
TickersSVA
ExchangesNasdaq
Entity typeother
CategoryAccelerated filer
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationB9 Antigua and Barbuda
Phone86-10-82799800
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • NET FORCE SYSTEMS INC (2000-01-20T00:00:00.000Z → 2004-01-13T00:00:00.000Z)
Business address
NO. 39 SHANGDI XI ROAD
HAIDIAN DISTRICT
BEIJING
100085
China
F4
CHINA
Mailing address
NO. 39 SHANGDI XI ROAD
HAIDIAN DISTRICT
BEIJING
100085
China
F4
CHINA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

578 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-08-17 6-K 6-K 0001193125-26-353263 001-32371 261284866 34 495537
2026-07-15 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-078116 001-32371 261175799 34 28933
2026-06-15 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-068483 001-32371 261088971 34 16428
2026-06-05 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-065846 001-32371 261069546 34 165802
2026-06-05 20-F 20-F 0001193125-26-258534 001-32371 261067130 34 31548054 1 1
2026-05-29 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-062907 001-32371 261045709 34 22651
2026-05-21 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-059828 001-32371 261005888 34 20549
2026-05-08 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-054027 001-32371 26959932 34 282171
2026-05-07 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-053039 001-32371 26950798 34 12063
2026-04-30 NT 20-F NOTIFICATION OF LATE FILING 0001213900-26-049775 001-32371 26920582 34 22246
2026-04-30 20-F 20-F 0001193125-26-194394 001-32371 26920543 34 47733752 1 1
2026-04-17 3 xslF345X06/ownership.xml 0001213900-26-044883 5848
2026-03-18 3 xslF345X06/ownership.xml 0001213900-26-029904 12025
2026-03-18 3 xslF345X06/ownership.xml 0001213900-26-029894 11786
2026-03-18 3 xslF345X06/ownership.xml 0001213900-26-029885 11807
2026-03-18 3 xslF345X06/ownership.xml 0001213900-26-029883 11517
2026-03-18 3 xslF345X06/ownership.xml 0001213900-26-029866 11407
2026-03-18 3 xslF345X06/ownership.xml 0001213900-26-029856 10866
2026-03-18 3 xslF345X06/ownership.xml 0001213900-26-029850 11457
2026-03-18 3 xslF345X06/ownership.xml 0001213900-26-029840 11142
2026-03-18 3 xslF345X06/ownership.xml 0001213900-26-029807 13176
2026-03-18 3 xslF345X06/ownership.xml 0001213900-26-029801 10886
2026-03-18 3 xslF345X06/ownership.xml 0001213900-26-029794 11147
2026-03-18 3 xslF345X06/ownership.xml 0001213900-26-029784 4847
2026-01-22 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-006442 001-32371 26582951 34 18464
2026-01-05 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-000752 001-32371 26582955 34 28604
2025-12-17 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-122528 001-32371 26582958 34 20450
2025-12-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-121832 005-79318 26582956 34 141232
2025-11-20 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-112846 001-32371 26582964 34 22984
2025-11-05 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-106469 001-32371 26582965 34 19929
2025-09-12 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193805-25-001290 005-79318 26582968 34 2075807
2025-08-21 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-079141 001-32371 26582974 34 15435
2025-07-15 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-067910 005-79318 251123030 34 8591
2025-07-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-067533 005-79318 251120085 34 13988
2025-07-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-067508 005-79318 251120062 34 12468
2025-07-11 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-063364 005-79318 251119802 34 33942
2025-07-11 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-062937 001-32371 251117420 34 31884
2025-07-10 6-K FORM 6-K 0001104659-25-066785 001-32371 251114705 34 38410
2025-07-10 6-K FORM 6-K 0001104659-25-066784 001-32371 251114704 34 25691
2025-07-08 6-K FORM 6-K 0001104659-25-066303 001-32371 251109675 34 131014
2025-07-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001214659-25-010107 005-79318 251109413 34 14471
2025-07-03 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001214659-25-010065 005-79318 251106862 34 18786
2025-07-02 6-K FORM 6-K 0001104659-25-065397 001-32371 251102398 34 41032
2025-07-01 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001214659-25-009866 005-79318 251094734 34 18786
2025-06-30 6-K FORM 6-K 0001104659-25-063805 001-32371 251088720 34 69434
2025-06-25 6-K FORM 6-K 0001104659-25-062292 001-32371 251070817 34 5085909
2025-06-20 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-060858 005-79318 251059019 34 8595
2025-06-20 6-K FORM 6-K 0001104659-25-060760 001-32371 251058803 34 22023
2025-06-18 6-K FORM 6-K 0001104659-25-060584 001-32371 251056288 34 684911
2025-06-18 6-K FORM 6-K 0001104659-25-060476 001-32371 251055166 34 39965
2025-06-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-060030 005-79318 251051765 34 96335
2025-06-13 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-054408 005-79318 251048010 34 42265
2025-05-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-052435 005-79318 25982373 34 33465
2025-05-23 6-K FORM 6-K 0001104659-25-052180 001-32371 25979190 34 20116
2025-05-20 6-K FORM 6-K 0001104659-25-050689 001-32371 25966085 34 30628
2025-05-19 6-K FORM 6-K 0001104659-25-050158 001-32371 25961406 34 11136
2025-04-30 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-041682 005-79318 25890667 34 8366
2025-04-30 6-K FORM 6-K 0001104659-25-041640 001-32371 25890633 34 45079
2025-04-29 NT 20-F NT 20-F 0001104659-25-041192 001-32371 25886985 34 24426
2025-04-29 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-041188 005-79318 25886950 34 39350
2025-04-24 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-035118 005-79318 25868719 34 22275
2025-04-21 6-K FORM 6-K 0001104659-25-036821 001-32371 25853047 34 28342
2025-04-10 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-033516 005-79318 25826413 34 14065
2025-04-01 6-K FORM 6-K 0001104659-25-030113 001-32371 25796352 34 19208
2025-03-31 6-K FORM 6-K 0001104659-25-029531 001-32371 25788567 34 16519
2025-03-25 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-027613 005-79318 25766309 34 29345
2025-03-21 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-026740 005-79318 25761945 34 10394
2025-03-19 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-024983 005-79318 25752228 34 14419
2025-03-19 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-025312 005-79318 25750766 34 45705
2025-02-28 6-K FORM 6-K 0001104659-25-018643 001-32371 25682576 34 19262
2025-02-19 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-015148 005-79318 25639786 34 35774
2025-01-16 6-K FORM 6-K 0001104659-25-003961 001-32371 25534399 34 16685
2024-09-12 SC 13D/A SC 13D/A 0001104659-24-099309 005-79318 241294933 34 84999
2024-08-16 6-K FORM 6-K 0001104659-24-090514 001-32371 241216887 34 232443
2024-06-17 SC 13D/A SC 13D/A 0001104659-24-072251 005-79318 241048151 34 82627
2024-04-30 6-K FORM 6-K 0001104659-24-054243 001-32371 24893277 34 295404
2024-04-29 20-F 20-F 0000950170-24-049936 001-32371 24891488 34 18340779 1 1
2024-03-20 SC 13G/A SC 13G/A 0001104659-24-036413 005-79318 24766289 34 68904
2024-03-18 SC TO-T/A FINAL AMENDMENT 0001870412-24-000004 005-79318 24756377 34 20359
2024-02-21 8-A12B/A 8-A12B/A 0001104659-24-025750 001-32371 24656306 34 26338
2024-02-21 6-K FORM 6-K 0001104659-24-025740 001-32371 24656279 34 46749
2024-02-02 SC TO-T/A COVER SHEET 0001870412-24-000002 005-79318 24589371 34 147329
2024-01-19 UPLOAD filename1.pdf 0000000000-24-000713 005-79318 52330
2024-01-18 SC 14D9 SC 14D9 0001104659-24-004667 005-79318 24540113 34 68842
2024-01-08 SC TO-T COVER SHEET 0001870412-24-000001 005-79318 24520784 34 152237
2023-12-04 SC 13D/A SC 13D/A 0001104659-23-122963 005-79318 231461190 34 80592
2023-10-10 UPLOAD filename1.pdf 0000000000-23-011070 39625
2023-10-05 CORRESP filename1.htm 0001104659-23-106962 29740
2023-10-03 SC TO-T/A sinovac_sc_to_a.htm 0001870412-23-000003 005-79318 231301749 34 20194
2023-09-15 SC 13D/A SC 13D/A 0001104659-23-101005 005-79318 231256794 34 81750
2023-09-11 6-K FORM 6-K 0001104659-23-099438 001-32371 231246620 34 41082
2023-09-08 UPLOAD filename1.pdf 0000000000-23-009960 43881
2023-09-05 SC 14D9 SC 14D9 0001104659-23-097975 005-79318 231234113 34 68075
2023-09-01 CORRESP filename1.htm 0001104659-23-097780 86053
2023-08-29 6-K FORM 6-K 0001104659-23-096182 001-32371 231217950 34 16883
2023-08-28 6-K FORM 6-K 0001104659-23-095733 001-32371 231210654 34 18631
2023-08-25 SC TO-T COVER SHEET 0001870412-23-000002 005-79318 231203275 34 142836
2023-08-15 6-K FORM 6-K 0001104659-23-091661 001-32371 231173158 34 198038
2023-07-21 UPLOAD filename1.pdf 0000000000-23-007795 45082
2023-07-10 CORRESP filename1.htm 0001193125-23-184598 222855
2023-06-26 UPLOAD filename1.pdf 0000000000-23-006783 63756
2023-05-25 SC 13D/A SC 13D/A 0001104659-23-064358 005-79318 23956187 34 67338
2023-05-01 6-K FORM 6-K 0001104659-23-053507 001-32371 23870027 34 288950
2023-05-01 6-K FORM 6-K 0001104659-23-053310 001-32371 23869642 34 13340
2023-05-01 20-F 20-F 0000950170-23-015997 001-32371 23869631 34 20944665 1 1
2023-03-15 SC 13D/A SC 13D/A 0001104659-23-032441 005-79318 23733181 34 80725
2023-02-22 8-A12B/A 8-A12B/A 0001104659-23-024005 001-32371 23650471 34 24289
2023-02-22 6-K FORM 6-K 0001104659-23-024000 001-32371 23650469 34 45520
2022-12-29 6-K FORM 6-K 0001104659-22-130697 001-32371 221496394 34 207152
2022-12-12 SC 13D/A SC 13D/A 0001104659-22-126053 005-79318 221456103 34 203151
2022-11-04 6-K FORM 6-K 0001104659-22-114701 001-32371 221360204 34 38066
2022-06-09 6-K FORM 6-K 0001104659-22-069453 001-32371 221004891 34 20147
2022-05-06 6-K FORM 6-K 0001104659-22-056701 001-32371 22898742 34 17789
2022-05-02 6-K FORM 6-K 0001104659-22-053915 001-32371 22878403 34 295141
2022-04-29 20-F 20-F 0001564590-22-016857 001-32371 22877724 34 18883935 1 1
2022-02-22 8-A12B/A 8-A12B/A 0001104659-22-025435 001-32371 22655564 34 21949
2022-02-22 6-K FORM 6-K 0001104659-22-025433 001-32371 22655555 34 42816
2021-12-30 6-K FORM 6-K 0001104659-21-154709 001-32371 211533021 34 189999
2021-12-13 6-K 6-K 0001104659-21-149065 001-32371 211488072 34 13786
2021-12-10 6-K 6-K 0001104659-21-148316 001-32371 211483578 34 20187
2021-12-07 6-K FORM 6-K 0001104659-21-146949 001-32371 211474603 34 20492
2021-11-10 6-K FORM 6-K 0001104659-21-136595 001-32371 211394294 34 21020
2021-07-20 6-K FORM 6-K 0001104659-21-093760 001-32371 211099601 34 26563
2021-07-20 6-K FORM 6-K 0001104659-21-093758 001-32371 211099600 34 19603
2021-07-12 6-K FORM 6-K 0001104659-21-090882 001-32371 211084261 34 47912
2021-06-30 6-K FORM 6-K 0001104659-21-087545 001-32371 211061938 34 28379
2021-06-02 6-K FORM 6-K 0001104659-21-075713 001-32371 21989057 34 22269
2021-04-23 6-K FORM 6-K 0001193125-21-127254 001-32371 21846300 34 215082
2021-04-22 20-F 20-F 0001564590-21-020156 001-32371 21845704 34 19050686 1 1
2021-04-02 6-K FORM 6-K 0001104659-21-045970 001-32371 21801252 34 20238
2021-02-22 8-A12B/A 8-A12B/A 0001104659-21-026219 001-32371 21660924 34 20386
2021-02-22 6-K 6-K 0001104659-21-026215 001-32371 21660875 34 42795
2021-02-08 6-K FORM 6-K 0001104659-21-013366 001-32371 21598704 34 44700
2020-12-22 SC 13D SC 13D 0001104659-20-138396 005-79318 201406330 34 226127
2020-12-21 SC 13D/A AMENDMENT NO. 3 0001214659-20-010560 005-79318 201402145 34 196041
2020-12-09 6-K 6-K 0001104659-20-133419 001-32371 201376922 34 21558
2020-12-07 6-K 6-K 0001104659-20-132664 001-32371 201371465 34 310938
2020-09-29 6-K 6-K 0001104659-20-109473 001-32371 201205964 34 17947
2020-09-23 6-K 6-K 0001104659-20-107666 001-32371 201191216 34 20280
2020-09-23 6-K 6-K 0001104659-20-107664 001-32371 201191213 34 20378
2020-08-28 6-K FORM 6-K 0001104659-20-100245 001-32371 201148643 34 285551
2020-08-26 6-K FORM 6-K 0001104659-20-098489 001-32371 201134073 34 37155
2020-07-06 6-K FORM 6-K 0001104659-20-080953 001-32371 201012307 34 39302
2020-06-30 6-K 6-K 0001104659-20-078469 001-32371 201000751 34 199836
2020-06-24 6-K FORM 6-K 0001104659-20-076447 001-32371 20985913 34 37407
2020-06-15 6-K 6-K 0001104659-20-073145 001-32371 20961897 34 19705
2020-06-11 6-K FORM 6-K 0001104659-20-072241 001-32371 20956311 34 20558
2020-05-22 6-K 6-K 0001104659-20-065137 001-32371 20903760 34 24627
2020-05-18 6-K 6-K 0001104659-20-063161 001-32371 20889483 34 23399
2020-05-06 6-K 6-K 0001104659-20-057275 001-32371 20851640 34 23185
2020-04-30 6-K FORM 6-K 0001104659-20-054500 001-32371 20836298 34 276055
2020-04-30 20-F 20-F 0001564590-20-020204 001-32371 20836058 34 15848504 1
2020-04-17 6-K 6-K 0001104659-20-047952 001-32371 20797865 34 49241
2020-04-14 6-K FORM 6-K 0001104659-20-046372 001-32371 20791543 34 36760
2020-02-21 8-A12B/A 8-A12B/A 0001104659-20-023911 001-32371 20640441 34 18625
2020-02-21 6-K 6-K 0001104659-20-023900 001-32371 20640348 34 39698
2019-12-31 6-K 6-K 0001104659-19-076914 001-32371 191317778 34 22479
2019-11-18 6-K FORM 6-K 0001104659-19-064902 001-32371 191226207 34 299738
2019-08-16 6-K FORM 6-K 0001144204-19-040319 001-32371 191031485 34 304246
2019-07-11 6-K FORM 6-K 0001144204-19-034351 001-32371 19950310 34 195584
2019-04-30 6-K FORM 6-K 0001144204-19-022195 001-32371 19779167 34 287650
2019-04-29 20-F 20-F 0001564590-19-013766 001-32371 19776751 34 16889684 1
2019-04-16 6-K 6-K 0001144204-19-019804 001-32371 19750082 34 29364
2019-04-15 6-K 6-K 0001144204-19-019580 001-32371 19747502 34 21992
2019-03-19 SC 13D/A AMENDMENT NO. 2 0000929638-19-000368 005-79318 19692643 34 40067
2019-03-11 6-K FORM 6-K 0001144204-19-013112 001-32371 19670492 34 22964
2019-02-22 8-A12B 8-A12B 0001144204-19-009658 001-32371 19626739 34 32939
2019-02-22 6-K FORM 6-K 0001144204-19-009657 001-32371 19626728 34 597740
2019-02-22 8-A12G 8-A12G 0001144204-19-009655 000-29031 19626718 34 60354
2018-12-20 6-K 6-K 0001144204-18-065492 001-32371 181244567 34 22109
2018-12-13 6-K 6-K 0001144204-18-064346 001-32371 181232106 34 24534
2018-11-28 6-K FORM 6-K 0001144204-18-062066 001-32371 181206477 34 20649
2018-11-08 6-K FORM 6-K 0001144204-18-058119 001-32371 181168174 34 167471
2018-10-22 6-K FORM 6-K 0001144204-18-054648 001-32371 181131515 34 22441
2018-10-17 6-K 6-K 0001144204-18-054099 001-32371 181125407 34 20142
2018-10-16 6-K 6-K 0001144204-18-053908 001-32371 181123478 34 18078
2018-10-10 6-K 6-K 0001144204-18-053084 001-32371 181114820 34 27991
2018-09-17 6-K 6-K 0001144204-18-049587 001-32371 181072413 34 17891
2018-08-27 SC 13D/A SC 13D/A 0001615774-18-008663 005-79318 181039240 34 89457
2018-08-20 6-K FORM 6-K 0001144204-18-045446 001-32371 181027169 34 19876
2018-07-23 SC 13E3/A SC 13E3/A 0001144204-18-039200 005-79318 18963626 34 68682
2018-07-20 SC 13D/A SC 13D/A 0001615774-18-006725 005-79318 18962772 34 112845
2018-07-11 SC 13D SC 13D 0001615774-18-006389 005-79318 18948956 34 49382
2018-07-10 SC 13G SCHEDULE 13G FOR SINOVAC BIOTECH LTD. BY PRIME SUCCSSS, L.P. 0000904454-18-000467 005-79318 18946204 34 95817
2018-07-03 8-A12B/A 8-A12B/A 0001144204-18-037079 001-32371 18934846 34 26691
2018-07-03 6-K FORM 6-K 0001144204-18-037077 001-32371 18934836 34 846908
2018-06-26 6-K 6-K 0001144204-18-035710 001-32371 18918425 34 27224
2018-06-11 6-K FORM 6-K 0001144204-18-033664 001-32371 18891080 34 19670
2018-05-11 6-K FORM 6-K 0001144204-18-027622 001-32371 18826796 34 282949
2018-05-11 20-F FORM 20-F 0001144204-18-027303 001-32371 18825075 34 12379630 1
2018-05-08 6-K 6-K 0001144204-18-026108 001-32371 18814434 34 24413
2018-05-08 NT 20-F/A NT 20-F/A 0001144204-18-025875 001-32371 18813210 34 26601
2018-05-02 6-K FORM 6-K 0001144204-18-024580 001-32371 18797545 34 22365
2018-04-30 NT 20-F NT 20-F 0001144204-18-023852 001-32371 18789928 34 25672
2018-04-30 6-K 6-K 0001144204-18-023594 001-32371 18787601 34 31447
2018-04-27 6-K 6-K 0001144204-18-022879 001-32371 18781183 34 20908
2018-04-27 6-K FORM 6-K 0001144204-18-022874 001-32371 18781145 34 46813
2018-04-23 6-K 6-K 0001144204-18-021870 001-32371 18769571 34 25019
2018-04-19 6-K 6-K 0001144204-18-021267 001-32371 18762619 34 20150
2018-04-19 6-K 6-K 0001144204-18-021255 001-32371 18762486 34 18110
2018-03-27 6-K 6-K 0001144204-18-017019 001-32371 18714136 34 38278
2018-03-26 SC 13D/A AMENDMENT NO. 1 0001214659-18-002332 005-79318 18711301 34 32042
2018-03-15 6-K FORM 6-K 0001144204-18-014790 001-32371 18690993 34 19642
2018-03-06 8-A12B/A 8-A12B/A 0001144204-18-013077 001-32371 18670054 34 21406
2018-03-06 6-K 6-K 0001144204-18-013074 001-32371 18670026 34 46795
2018-03-06 6-K 6-K 0001144204-18-012931 001-32371 18668573 34 32519
2018-02-08 SC 13G/A SEC SCHEDULE 13G 0000902219-18-000018 005-79318 18583511 34 33151
2018-02-07 6-K 6-K 0001144204-18-006114 001-32371 18579413 34 28593
2018-01-30 SC 13E3/A SCHEDULE 13E3/A 0001144204-18-004421 005-79318 18557414 34 5853751
2018-01-30 CORRESP filename1.htm 0001144204-18-004422 62529
2018-01-22 UPLOAD filename1.pdf 0000000000-18-002196 214346
2018-01-05 SC 13E3 SCHEDULE 13E3 0001144204-18-000917 005-79318 18512049 34 9766765
2017-12-29 6-K 6-K 0001144204-17-065708 001-32371 171279755 34 22485
2017-12-01 6-K 6-K 0001144204-17-061781 001-32371 171232667 34 15449
2017-12-01 6-K 6-K 0001144204-17-061780 001-32371 171232662 34 185865
2017-11-30 6-K FORM 6-K 0001144204-17-061585 001-32371 171229893 34 16316
2017-11-22 6-K 6-K 0001144204-17-060691 001-32371 171220281 34 362297
2017-11-22 20-F FORM 20-F 0001144204-17-060660 001-32371 171220007 34 13987774 1
2017-11-08 6-K FORM 6-K 0001144204-17-057299 001-32371 171186978 34 15784
2017-11-03 6-K FORM 6-K 0001144204-17-056214 001-32371 171176806 34 17203
2017-08-14 6-K 6-K 0001144204-17-042642 001-32371 171027308 34 24985
2017-07-07 SC 13D d77170sc13d.htm 0001214659-17-004388 005-79318 17955839 34 40932
2017-06-30 8-A12B/A 8-A12B/A 0001144204-17-035055 001-32371 17940289 34 23131
2017-06-30 6-K FORM 6-K 0001144204-17-035049 001-32371 17940275 34 50575
2017-06-27 SC 13D/A SC 13D/A 0001144204-17-034230 005-79318 17931196 34 89693
2017-06-27 SC 13D/A SC 13D/A 0001144204-17-034228 005-79318 17931191 34 723037
2017-06-26 6-K FORM 6-K 0001144204-17-033924 001-32371 17929009 34 491908
2017-05-16 6-K 6-K 0001144204-17-027949 001-32371 17848992 34 22484
2017-05-01 NT 20-F NT 20-F 0001144204-17-023450 001-32371 17798490 34 21406
2017-03-24 8-A12B/A FORM 8-A12B/A 0001144204-17-016366 001-32371 17711165 34 19909
2017-03-24 6-K 6-K 0001144204-17-016364 001-32371 17711162 34 42393
2017-02-09 SC 13G/A SEC SCHEDULE 13G 0000902219-17-000376 005-79318 17585892 34 37721
2017-02-08 6-K FORM 6-K 0001144204-17-006584 001-32371 17580815 34 281251
2016-12-23 6-K 6-K 0001144204-16-141104 001-32371 162067902 34 17026
2016-11-08 6-K FORM 6-K 0001144204-16-132234 001-32371 161979855 34 16506
2016-10-21 6-K FORM 6-K 0001144204-16-128847 001-32371 161945323 34 20530
2016-10-11 6-K FORM 6-K 0001144204-16-127478 001-32371 161929217 34 87720
2016-08-24 6-K FORM 6-K 0001144204-16-120848 001-32371 161848212 34 316266
2016-06-02 6-K FORM 6-K 0001144204-16-106395 001-32371 161691121 34 187186 1
2016-04-25 20-F FORM 20-F 0001144204-16-096074 001-32371 161589106 34 12765638 1
2016-04-14 6-K FORM 6-K 0001144204-16-094216 001-32371 161570383 34 17457 1
2016-04-12 6-K FORM 6-K 0001144204-16-093792 001-32371 161566259 34 206247 1
2016-04-11 SC 13G p48161sc13g.htm 0001214659-16-010806 005-79318 161563689 34 88439
2016-04-05 SC 13G/A AMENDMENT NO. 1 0001214659-16-010711 005-79318 161555496 34 93790
2016-03-29 8-A12B 8-A12B 0001144204-16-090765 001-32371 161533709 34 32014
2016-03-29 6-K FORM 6-K 0001144204-16-090752 001-32371 161533538 34 417647 1
2016-02-11 SC 13G/A SCHEDULE 13G/A 0001172661-16-002574 005-79318 161412357 34 92825
2016-02-11 SC 13G/A SEC SCHEDULE 13G 0000902219-16-001042 005-79318 161410913 34 37601
2016-02-08 SC 13D/A SC 13D/A 0001144204-16-079377 005-79318 161393823 34 53875
2016-02-04 6-K FORM 6-K 0001144204-16-078903 001-32371 161386755 34 41970
2016-02-02 SC 13D/A SC 13D/A 0001144204-16-078307 005-79318 161379105 34 96879
2016-02-01 6-K FORM 6-K 0001144204-16-077979 001-32371 161375340 34 29033
2016-02-01 6-K FORM 6-K 0001144204-16-077977 001-32371 161375335 34 18875
2016-01-05 6-K FORM 6-K 0001144204-16-073903 001-32371 161319873 34 26823
2015-11-13 6-K FORM 6-K 0001144204-15-064935 001-32371 151226749 34 258292
2015-11-06 6-K FORM 6-K 0001144204-15-063200 001-32371 151202350 34 17621
2015-11-02 6-K FORM 6-K 0001144204-15-062046 001-32371 151189045 34 19842
2015-09-15 6-K FORM 6-K 0001144204-15-054920 001-32371 151106644 34 20017
2015-08-13 6-K FORM 6-K 0001144204-15-048685 001-32371 151048540 34 186117
2015-05-15 6-K FORM 6-K 0001144204-15-030991 001-32371 15865409 34 125923
2015-05-14 6-K FORM 6-K 0001144204-15-030365 001-32371 15860204 34 16584
2015-05-12 6-K FORM 6-K 0001144204-15-029730 001-32371 15854429 34 16155
2015-05-07 6-K FORM 6-K 0001144204-15-028366 001-32371 15841627 34 14765
2015-04-29 6-K 6-K 0001144204-15-025711 001-32371 15810183 34 17076
2015-04-29 20-F 20-F 0001104659-15-031226 001-32371 15809963 34 15402196 1
2015-04-29 6-K FORM 6-K 0001144204-15-025697 001-32371 15809940 34 239157
2015-04-15 6-K FORM 6-K 0001144204-15-022792 001-32371 15770456 34 41932
2015-02-17 SC 13G SCHEDULE 13G HOLDINGS REPORT 0001172661-15-000686 005-79318 15621855 34 93227
2015-02-12 SC 13G/A SEC SCHEDULE 13G 0000902219-15-000423 005-79318 15603383 34 20336
2014-11-17 6-K FORM 6-K 0001144204-14-069017 001-32371 141226270 34 256135
2014-08-27 6-K FORM 6-K 0001144204-14-052588 001-32371 141066777 34 18495
2014-08-19 6-K 6-K 0001144204-14-051174 001-32371 141050493 34 34873
2014-08-19 6-K 6-K 0001144204-14-051170 001-32371 141050483 34 230369
2014-07-16 6-K 6-K 0001144204-14-043264 001-32371 14976962 34 94482
2014-07-16 6-K 6-K 0001144204-14-043260 001-32371 14976947 34 18690
2014-06-24 6-K FORM 6-K 0001144204-14-039168 001-32371 14936320 34 214488
2014-04-28 6-K FORM 6-K 0001144204-14-025078 001-32371 14787372 34 32291
2014-04-16 20-F 20-F 0001104659-14-027985 001-32371 14766642 34 14950211 1
2014-03-24 6-K FORM 6-K 0001144204-14-017263 001-32371 14712258 34 187104
2014-03-05 SC 13D/A SC 13D/A 0001193125-14-082957 005-79318 14667274 34 122039
2014-02-14 SC 13G DISCLOSURE DOCUMENT 0000902219-14-000936 005-79318 14611442 34 19542
2014-01-27 6-K 6-K 0001144204-14-004061 001-32371 14547364 34 221003
2013-09-04 S-8 FORM S-8 0001144204-13-049215 333-190980 131078066 33 220595
2013-08-16 6-K FORM 6-K 0001144204-13-046435 001-32371 131043792 34 294688
2013-06-03 6-K FORM 6-K 0001144204-13-032762 001-32371 13886713 34 136263
2013-05-24 6-K FORM 6-K 0001144204-13-031455 001-32371 13870158 34 19967
2013-05-23 20-F/A 20-F/A 0001104659-13-044076 001-32371 13866681 34 10663444 1
2013-05-15 6-K FORM 6-K 0001144204-13-029001 001-32371 13843816 34 19542
2013-05-09 SC 13G c58131sc13g.htm 0001214659-13-002572 005-79318 13825969 34 90857
2013-05-03 6-K FORM 6-K 0001144204-13-026106 001-32371 13810221 34 939273
2013-04-30 20-F 20-F 0001104659-13-034657 001-32371 13794198 34 3222921
2013-02-14 SC 13G/A DISCLOSURE DOCUMENT 0000902219-13-000434 005-79318 13609760 34 19538
2012-12-28 SC 13D SINOVAC BIOTECH LTD. SCHEDULE 13D DECEMBER 27, 2012 0001005794-12-000074 005-79318 121288820 34 176523
2012-11-16 6-K FORM 6-K 0001144204-12-063373 001-32371 121210176 34 250044
2012-09-28 6-K FORM 6-K 0001144204-12-053389 001-32371 121114479 34 200724
2012-09-26 6-K FORM 6-K 0001144204-12-052942 001-32371 121110110 34 36923
2012-09-26 6-K FORM 6-K 0001144204-12-052940 001-32371 121110108 34 18052
2012-07-19 6-K FORM 6-K 0001144204-12-040068 001-32371 12968940 34 257619
2012-05-22 6-K FORM 6-K 0001144204-12-031135 001-32371 12860367 34 19146
2012-05-18 6-K FORM 6-K 0001144204-12-030456 001-32371 12853826 34 141922
2012-04-12 20-F 20-F 0001104659-12-024859 001-32371 12755396 34 7675534 1
2012-04-06 6-K 6-K 0001144204-12-020472 001-32371 12747031 34 240481
2012-04-06 6-K FORM 6-K 0001144204-12-020470 001-32371 12747030 34 31293
2012-02-14 SC 13G/A DISCLOSURE DOCUMENT 0000902219-12-000423 005-79318 12605108 34 19567
2012-02-06 6-K FORM 6-K 0001144204-12-005896 001-32371 12571932 34 30412
2012-01-26 SC 13G/A sva1.txt 0000906304-12-000328 005-79318 12548118 34 7611
2012-01-13 6-K CURRENT REPORT OF FOREIGN ISSUER FORM 6-K 0001144204-12-002146 001-32371 12525128 34 24617
2011-12-30 SC 13D/A SCHEDULE 13D/AMENDMENT NO. 4 0001193125-11-356334 005-79318 111289236 34 70649
2011-12-08 6-K CURRENT REPORT OF FOREIGN ISSUER 0001144204-11-068892 001-32371 111249808 34 491697
2011-11-29 SC 13D/A SCHEDULE 13D/AMENDMENT NO. 3 0000950123-11-100799 005-79318 111229598 34 56476
2011-09-30 SC 13D/A SCHEDULE 13D/AMENDMENT NO. 2 0000950123-11-087903 005-79318 111117000 34 56211
2011-08-23 SC 13D/A SCHEDULE 13D/AMENDMENT NO. 1 0000950123-11-079502 005-79318 111052078 34 53889
2011-08-17 6-K FORM 6-K 0001144204-11-048048 001-32371 111041145 34 458910
2011-08-08 6-K FORM 6-K 0001144204-11-044363 001-32371 111015599 34 26887
2011-07-20 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SE 0001144204-11-041219 001-32371 11976473 34 37812
2011-07-20 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SE 0001144204-11-041217 001-32371 11976472 34 52922
2011-07-11 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001144204-11-039889 001-32371 11960791 34 322829
2011-05-31 SC 13D SCHEDULE 13D 0000950123-11-055171 005-79318 11879716 34 75945
2011-04-22 20-F v219311_20f.htm 0001144204-11-023553 001-32371 11775217 34 2590096
2011-04-18 6-K v218785_6k.htm 0001144204-11-022648 001-32371 11764331 34 33147
2011-04-18 6-K v218786_6k.htm 0001144204-11-022647 001-32371 11764329 34 33541
2011-04-18 6-K v218787_6k.htm 0001144204-11-022646 001-32371 11764328 34 30167
2011-04-18 6-K v218788_6k.htm 0001144204-11-022645 001-32371 11764327 34 544643
2011-03-02 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0000950123-11-020988 005-79318 11654277 34 57201
2011-02-14 SC 13G/A SEC FILING 0000902219-11-000856 005-79318 11605354 34 20014
2011-02-10 SC 13G/A SEC FILING 0000902219-11-000469 005-79318 11591490 34 20015
2011-02-10 SC 13G/A SCHEDULE 13G/A 0000950123-11-011473 005-79318 11590152 34 63331
2011-02-04 SC 13G sva.txt 0000906304-11-000328 005-79318 11573984 34 8009
2011-01-12 6-K SINOVAC BIOTECH 6K, 01.11.11 0001127855-11-000008 001-32371 11524464 34 34135
2011-01-04 6-K 6-K 0001104659-11-000167 001-32371 11503237 34 37737
2010-11-16 6-K 6-K 0001104659-10-058646 001-32371 101195522 34 445722
2010-11-15 SC 13G SCHEDULE 13G 0000950123-10-105297 005-79318 101189131 34 70531
2010-11-10 SC 13G SEC FILING 0000902219-10-001034 005-79318 101179928 34 20002
2010-10-25 6-K 6-K 0001104659-10-053392 001-32371 101138828 34 53299
2010-08-25 UPLOAD filename1.pdf 0000000000-10-049194 50810
2010-08-17 6-K 6-K 0001104659-10-044700 001-32371 101021713 34 485279
2010-07-22 CORRESP filename1.htm 0001104659-10-038999 40802
2010-07-19 6-K 6-K 0001104659-10-038415 001-32371 10957423 34 28156
2010-07-13 UPLOAD filename1.pdf 0000000000-10-039329 68170
2010-07-08 6-K 6-K 0001104659-10-037386 001-32371 10943423 34 44657
2010-06-21 6-K 6-K 0001104659-10-034675 001-32371 10907044 34 167913
2010-06-15 CORRESP filename1.htm 0001104659-10-033796 58802
2010-05-28 UPLOAD filename1.pdf 0000000000-10-029883 31280
2010-05-19 6-K 6-K 0001104659-10-029475 001-32371 10844343 34 380782
2010-04-16 20-F 20-F 0001104659-10-019961 001-32371 10753436 34 3047276
2010-04-07 6-K 6-K 0001104659-10-018646 001-32371 10735704 34 398682
2010-02-12 SC 13G/A ST-EXIT-MSCS 0000895421-10-000309 005-79318 10595008 34 18814
2010-01-28 6-K 6-K 0001104659-10-003435 001-32371 10552005 34 362271
2010-01-28 424B5 424B5 0001047469-10-000384 333-163165 10551927 33 718034
2010-01-27 F-3MEF F-3MEF 0001047469-10-000378 333-164559 10551804 33 99490
2010-01-20 424B5 424B5 0001047469-10-000233 333-163165 10536813 33 722011
2010-01-20 6-K 6-K 0001104659-10-002282 001-32371 10536704 34 268409
2010-01-20 20-F/A 20-F/A 0001104659-10-002271 001-32371 10536446 34 399819
2009-12-02 424B3 424(B)(3) 0001047469-09-010511 333-163165 091216217 33 158054
2009-11-30 EFFECT xslEFFECTX01/primary_doc.xml F-3,,2009-11-30 10:00:00 9999999995-09-003328 333-163165 091213469 33 2228
2009-11-27 6-K 6-K 0001104659-09-067210 001-32371 091209431 34 32907
2009-11-18 6-K 6-K 0001104659-09-065619 001-32371 091192036 34 449392
2009-11-18 F-3 F-3 0001047469-09-010280 333-163165 091192021 33 260671
2009-11-18 6-K 6-K 0001104659-09-065576 001-32371 091191965 34 982816
2009-11-13 CERTNAS AUTO-GENERATED PAPER DOCUMENT 9999999997-09-026595 001-32371 09012615 34 1839
2009-11-13 8-A12B 8-A12B 0001104659-09-064798 001-32371 091179800 34 34131
2009-11-13 25 25 0001104659-09-064792 001-32371 091179764 34 15190
2009-11-04 6-K SINOVAC BIOTECH 6K, 11.03.09 0001127855-09-000471 001-32371 091158250 34 35624
2009-09-30 6-K SINOVAC BIOTECH 6K, 08.19.09 0001127855-09-000416 001-32371 091094836 34 410539
2009-09-29 6-K SINOVAC BIOTECH 6K, 06.15.09 0001127855-09-000410 001-32371 091091784 34 302284
2009-09-28 6-K SINOVAC BIOTECH 6K, 09.16.09 0001127855-09-000406 001-32371 091089431 34 29510
2009-09-28 6-K SINOVAC BIOTECH 6K, 09.08.09 0001127855-09-000404 001-32371 091089423 34 29859
2009-09-28 6-K SINOVAC BIOTECH 6K, 09.04.09 0001127855-09-000402 001-32371 091089413 34 34265
2009-09-28 6-K SINOVAC BIOTECH 6K, 09.03.09 0001127855-09-000400 001-32371 091089407 34 33791
2009-09-28 6-K SINOVAC BIOTECH 6K, 09.02.09 0001127855-09-000398 001-32371 091089401 34 35960
2009-09-28 6-K SINOVAC BIOTECH 6K, 08.31.09 0001127855-09-000396 001-32371 091089396 34 36043
2009-09-28 6-K SINOVAC BIOTECH 6K, 08.28.09 0001127855-09-000394 001-32371 091089391 34 35960
2009-09-10 SC 13G/A SCHEDULE 13G AMENDMENT NO. 5 0001193125-09-189782 005-79318 091062104 34 74910
2009-09-10 S-8 FORM S-8 0001193125-09-189781 333-161827 091062077 33 81997
2009-08-27 6-K SINOVAC BIOTECH 6K, 08.18.09 0001127855-09-000351 001-32371 091038573 34 35813
2009-08-27 6-K SINOVAC BIOTECH 6K, 08.11.09 0001127855-09-000349 001-32371 091038568 34 33317
2009-08-27 6-K SINOVAC BIOTECH 6K, 08.04.09 0001127855-09-000347 001-32371 091038553 34 36647
2009-08-27 6-K SINOVAC BIOTECH 6K, 08.03.09 0001127855-09-000345 001-32371 091038532 34 34110
2009-08-27 6-K SINOVAC BIOTECH 6K, 07.22.09 0001127855-09-000343 001-32371 091038528 34 34595
2009-08-27 6-K SINOVAC BIOTECH 6K, 07.16.09 0001127855-09-000341 001-32371 091038515 34 34424
2009-08-27 6-K SINOVAC BIOTECH 6K, 06.29.09 0001127855-09-000339 001-32371 091038497 34 35895
2009-08-27 6-K SINOVAC BIOTECH 6K, 06.19.09 0001127855-09-000337 001-32371 091038477 34 34578
2009-08-27 6-K SINOVAC BIOTECH 6K, 06.10.09 0001127855-09-000335 001-32371 091038456 34 33626
2009-08-27 6-K SINOVAC BIOTECH 6K, 06.08.09 0001127855-09-000333 001-32371 091038439 34 37054
2009-08-27 6-K SINOVAC BIOTECH 6K, 06.02.09 0001127855-09-000331 001-32371 091038415 34 36681
2009-08-20 20-F/A FORM 20-F/A AMENDMENT NO.1 0001193125-09-178612 001-32371 091025480 34 47247
2009-07-10 SC 13G/A SCHEDULE 13G AMENDMENT NO. 4 0001193125-09-147035 005-79318 09938591 34 74452
2009-05-06 6-K SINOVAC BIOTECH 6K, 05.01.09 0001127855-09-000189 001-32371 09801036 34 36540
2009-05-06 6-K SINOVAC BIOTECH 6K, 04.30.09 0001127855-09-000187 001-32371 09800943 34 39519
2009-05-06 6-K SINOVAC BIOTECH 6K, 04.28.09 0001127855-09-000185 001-32371 09800928 34 38362
2009-05-06 6-K SINOVAC BIOTECH 6K, 04.09.09 0001127855-09-000183 001-32371 09800819 34 1184279
2009-05-06 6-K SINOVAC BIOTECH 6K, 04.09.09 0001127855-09-000181 001-32371 09800806 34 76112
2009-05-06 6-K SINOVAC BIOTECH 6K, 04.01.09 0001127855-09-000179 001-32371 09800787 34 33934
2009-05-01 20-F SINOVAC BIOTECH 20-F, 12.31.08 0001127855-09-000170 001-32371 09787562 34 4518140
2009-03-12 6-K SINOVAC BIOTECH 6K, 03.09.09 0001127855-09-000070 001-32371 09674731 34 34584
2009-03-06 6-K SINOVAC BIOTECH 6K, 03.02.09 0001127855-09-000064 001-32371 09661496 34 34896
2009-03-06 6-K SINOVAC BIOTECH 6K, 01.26.09 0001127855-09-000062 001-32371 09661325 34 41582
2009-02-17 SC 13G/A ST - AMENDMENT - MSCS 0000895421-09-000152 005-79318 09609577 34 18374
2009-02-13 SC 13G/A SCHEDULE 13G AMENDMENT NO. 3 0001193125-09-028188 005-79318 09598035 34 73277
2009-01-08 6-K SINOVAC BIOTECH 6K, 12.31.08 0001127855-09-000002 001-32371 09515183 34 35409

Latest XBRL company facts

One latest value per concept from companyfacts (446 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 71.86M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
dei EntityPublicFloat Entity Public Float USD 0 2011-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 604.68M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 9.57M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 16.23M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 286.34M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 3.94M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AccretionExpense Accretion Expense USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap AccrualForTaxesOtherThanIncomeTaxesCurrent Accrual for Taxes Other than Income Taxes, Current USD 799,000 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 30.69M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 152.71M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 9.41M 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 0 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 591.73M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment (Deprecated 2015-01-31) USD -454,973 2011-01-01 2011-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -513.25M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 550.17M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest Adjustments to Additional Paid in Capital, Reallocation of Noncontrolling Interest (Deprecated 2013-01-31) USD 115,677 2009-01-01 2009-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 7.74M 2021-01-01 2021-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 4.28M 2010-01-01 2010-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap AdvertisingExpense Advertising Expense USD 1.17M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 29.05M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 29.05M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 333,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 1.33M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries Amount of Restricted Net Assets for Consolidated and Unconsolidated Subsidiaries USD 4.44B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap Assets Assets USD 8.54B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AssetsCurrent Assets, Current USD 7.06B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 0 2016-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap AssetsNoncurrent Assets, Noncurrent USD 1.48B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 1.80M 2015-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 113.28M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 7.70B 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap BusinessAcquisitionPercentageOfVotingInterestsAcquired Business Acquisition, Percentage of Voting Interests Acquired pure 0.25 2010-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred CNY 13.00M 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 6.15M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 0 2014-12-31 2014 FY 20-F 2015-04-29 0001104659-15-031226
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 488.25M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 51.98M 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 1.16B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 1.13B 2023-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 554.21M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations Cash Provided by (Used in) Financing Activities, Discontinued Operations USD 0 2015-01-01 2015-12-31 2015 FY 20-F 2016-04-25 0001144204-16-096074
us-gaap CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations Cash Provided by (Used in) Investing Activities, Discontinued Operations USD -9,000 2016-01-01 2016-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD -95,000 2016-01-01 2016-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 30 2015-12-31 2015 FY 20-F 2016-04-25 0001144204-16-096074
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 55 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 71.86M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 71.86M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap CommonStockValue Common Stock, Value, Issued USD 72,000 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 134.87M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD -53.01M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 81.86M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesAdditionalInterestIssuedToParent Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Additional Interest Issued to Parent CNY 80.00M 2016-09-29 2016-10-01 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 3.71M 2023-01-01 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ContractWithCustomerRefundLiability Contract with Customer, Refund Liability USD 37.32M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ContractWithCustomerRefundLiabilityNoncurrent Contract with Customer, Refund Liability, Noncurrent USD 0 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap ContractWithCustomerRightToRecoverProduct Contract with Customer, Right to Recover Product USD 31.57M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap CostOfRevenue Cost of Revenue USD 124.03M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD -696,000 2014-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 26.64M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DebtCurrent Debt, Current USD 3.32M 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate pure 0.016 2019-10-21 2019-11-20 2019 FY 20-F 2020-04-30 0001564590-20-020204
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.07 2013-01-01 2013-12-31 2013 FY 20-F 2014-04-16 0001104659-14-027985
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.068 2014-12-31 2014 FY 20-F 2015-04-29 0001104659-15-031226
us-gaap DebtLongtermAndShorttermCombinedAmount Debt, Long-term and Short-term, Combined Amount USD 494.86M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DebtSecurities Debt Securities USD 435.84M 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap DebtSecuritiesAvailableForSaleGainLoss Debt Securities, Available-for-sale, Gain (Loss) USD 182.71M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DebtSecuritiesHeldToMaturityAllowanceForCreditLoss Debt Securities, Held-to-maturity, Allowance for Credit Loss USD 0 2021-12-31 2021 FY 20-F 2022-04-29 0001564590-22-016857
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 41.52M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -89.91M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 377.31M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 325.07M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredRevenue Deferred Revenue USD 429,416 2011-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 11.27M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 0 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap DeferredRevenueRevenueRecognized Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) USD -104,000 2014-01-01 2014-12-31 2014 FY 20-F 2015-04-29 0001104659-15-031226
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 9.25M 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 503.69M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 18.82M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredTaxAssetsLiabilitiesNetCurrent Deferred Tax Assets, Net, Current USD 3.49M 2016-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 11.37M 2019-12-31 2019 FY 20-F 2020-04-30 0001564590-20-020204
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 93.77M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 11.37M 2019-12-31 2019 FY 20-F 2020-04-30 0001564590-20-020204
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 3.49M 2016-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 374.11M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 3.98M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 5.38M 2020-12-31 2020 FY 20-F 2021-04-22 0001564590-21-020156
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 83.31M 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts USD 511,812 2012-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 29.59M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 409.92M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredTaxAssetsValuationAllowanceCurrent Deferred Tax Assets, Valuation Allowance, Current USD 2.77M 2019-12-31 2019 FY 20-F 2020-04-30 0001564590-20-020204
us-gaap DeferredTaxAssetsValuationAllowanceNoncurrent Deferred Tax Assets, Valuation Allowance, Noncurrent USD 7.99M 2016-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 325.07M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredTaxLiabilitiesCurrent Deferred Tax Liabilities, Net, Current USD 1.01M 2010-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost USD 13.05M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredTaxLiabilitiesTaxDeferredIncome Deferred Tax Liabilities, Tax Deferred Income USD 30.74M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DeferredTaxLiabilitiesUndistributedForeignEarnings Deferred Tax Liabilities, Undistributed Foreign Earnings USD 310.66M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 13.86M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap Depreciation Depreciation USD 97.45M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1.59M 2012-01-01 2012-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 4.49M 2012-01-01 2012-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax USD 0 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share USD/shares 0 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share USD/shares 0 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap DiscontinuedOperationTaxEffectOfDiscontinuedOperation Discontinued Operation, Tax Effect of Discontinued Operation USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current USD 217,000 2015-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 0 2015-12-31 2015 FY 20-F 2016-04-25 0001144204-16-096074
us-gaap DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents USD 143,000 2015-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold Disposal Group, Including Discontinued Operation, Costs of Goods Sold USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense Disposal Group, Including Discontinued Operation, General and Administrative Expense USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss Disposal Group, Including Discontinued Operation, Gross Profit (Loss) USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingExpense Disposal Group, Including Discontinued Operation, Operating Expense USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss Disposal Group, Including Discontinued Operation, Operating Income (Loss) USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherAssets Disposal Group, Including Discontinued Operation, Other Assets USD 76,000 2015-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherLiabilities Disposal Group, Including Discontinued Operation, Other Liabilities USD 26,000 2015-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current USD 128,000 2015-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current USD 1.45M 2015-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap Dividends Dividends USD 3.98B 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 3.96B 2025-04-01 2025-04-30 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DividendsPayableCurrent Dividends Payable, Current USD 657.86M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 3.40M 2010-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 4.36M 2022-12-31 2022 FY 20-F 2023-05-01 0000950170-23-015997
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 4.36M 2022-12-31 2022 FY 20-F 2023-05-01 0000950170-23-015997
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 4.71M 2021-12-31 2022 FY 20-F 2023-05-01 0000950170-23-015997
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.83 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.02 2014-01-01 2014-12-31 2014 FY 20-F 2015-04-29 0001104659-15-031226
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.83 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.241 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.25 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.298 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.008 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.127 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 3.87M 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations USD -1.54M 2015-01-01 2015-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 112.93M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -108.85M 2023-01-01 2023-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 354.66M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EquityMethodInvestmentAggregateCost Equity Method Investment, Aggregate Cost USD 248.44M 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap EquityMethodInvestments Equity Method Investments USD 281.76M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap EquityRestrictions Equity Restrictions USD 11.81M 2011-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD -112,000 2020-12-31 2020 FY 20-F 2021-04-22 0001564590-21-020156
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 399,695 2012-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 350,524 2012-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 399,695 2012-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 1.59M 2020-12-31 2020 FY 20-F 2021-04-22 0001564590-21-020156
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 77.68M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap FiniteLivedLicenseAgreementsGross Finite-Lived License Agreements, Gross USD 1.34M 2011-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -109.79M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -74,000 2014-01-01 2014-12-31 2014 FY 20-F 2015-04-29 0001104659-15-031226
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 42,000 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -30.28M 2024-01-01 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap GainLossOnSalesOfAssetsAndAssetImpairmentCharges Gain (Loss) on Sale of Assets and Asset Impairment Charges USD -137.24M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap Goodwill Goodwill USD 12.60M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 27.51M 2024-01-01 2024-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD 782,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap GoodwillGross Goodwill, Gross USD 28.73M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap GoodwillImpairedAccumulatedImpairmentLoss Goodwill, Impaired, Accumulated Impairment Loss USD 16.12M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 15.69M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap GrossProfit Gross Profit USD 261.98M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap HeldToMaturitySecurities Debt Securities, Held-to-maturity USD 2.26B 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 49.92M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2024-01-01 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD 21.78M 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -338.96M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -262.10M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 76.86M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 216.62M 2020-01-01 2020-12-31 2020 FY 20-F 2021-04-22 0001564590-21-020156
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 36.11M 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares 1.27 2024-01-01 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares 1.27 2024-01-01 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 0 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 0 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -4.04M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions Income (Loss) from Equity Method Investments, Net of Dividends or Distributions USD -6.72M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeTaxesPaid Income Taxes Paid USD 1.32B 2022-01-01 2022-12-31 2022 FY 20-F 2023-05-01 0000950170-23-015997
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 186.48M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -63.27M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeTaxReceivable Income Taxes Receivable USD 4.22M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 78.03M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -10.72M 2024-01-01 2024-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -65.53M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -2.15M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD -178,176 2012-01-01 2012-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 0 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 282,000 2014-01-01 2014-12-31 2014 FY 20-F 2015-04-29 0001104659-15-031226
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 33.19M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 109.43M 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -24.27M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -177.17M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD 2.52M 2019-01-01 2019-12-31 2019 FY 20-F 2020-04-30 0001564590-20-020204
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -1.46M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 23.02M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net USD 8.74M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -3.05M 2022-01-01 2022-12-31 2022 FY 20-F 2023-05-01 0000950170-23-015997
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -2.10M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD -64,400 2010-01-01 2010-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap IncreaseDecreaseInRestrictedCashForOperatingActivities Increase (Decrease) in Restricted Cash for Operating Activities USD -1.60M 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap IncreaseDecreaseInTimeDeposits Increase (Decrease) in Time Deposits USD 1.50M 2015-01-01 2015-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible Increase in Unrecognized Tax Benefits is Reasonably Possible USD 162,000 2016-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 250,408 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 77.68M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 9.82M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap InterestCostsCapitalized Interest Costs Capitalized USD 0 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap InterestCostsIncurred Interest Costs Incurred USD 2.26M 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 354,000 2022-01-01 2022-12-31 2022 FY 20-F 2023-05-01 0000950170-23-015997
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 455,851 2011-01-01 2011-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 9.69M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 29.59M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap InventoryNet Inventory, Net USD 94.31M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 0 2019-12-31 2019 FY 20-F 2020-04-30 0001564590-20-020204
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 25.84M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 38.88M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap InventoryWriteDown Inventory Write-down USD 30.59M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 33.28M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap InvestmentIncomeNonoperating Investment Income, Nonoperating USD 190.81M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 2.80B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 12.20M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 2.17M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.33M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.94M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.92M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.92M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.92M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.44M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap Liabilities Liabilities USD 2.15B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 8.54B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.54B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 605.11M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Liabilities USD 243,000 2015-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2016-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 0 2015-12-31 2015 FY 20-F 2016-04-25 0001144204-16-096074
us-gaap LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party USD 0 2021-01-01 2021-12-31 2021 FY 20-F 2022-04-29 0001564590-22-016857
us-gaap LoansPayableCurrent Loans Payable, Current USD 0 2016-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap LongTermDebt Long-term Debt USD 494.86M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 171.77M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 229.37M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 23.11M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 5.08M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 3.69M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 61.84M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LongtermDebtPercentageBearingFixedInterestAmount Long-term Debt, Percentage Bearing Fixed Interest, Amount USD 1.86M 2015-12-31 2015 FY 20-F 2016-04-25 0001144204-16-096074
us-gaap LongTermInvestments Long-term Investments USD 512.32M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LongTermLoansFromBank Loans Payable to Bank, Noncurrent USD 265.48M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 265.48M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 1.96B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders USD 6.66M 2011-01-01 2011-12-31 2013 FY 20-F 2014-04-16 0001104659-14-027985
us-gaap MinorityInterestDecreaseFromRedemptions Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests USD 7.56M 2010-01-01 2010-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD 2.70M 2011-01-01 2011-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap NetCashProvidedByUsedInDiscontinuedOperations Net Cash Provided by (Used in) Discontinued Operations USD 82,000 2015-01-01 2015-12-31 2015 FY 20-F 2016-04-25 0001144204-16-096074
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -3.43B 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -24.20M 2015-01-01 2015-12-31 2015 FY 20-F 2016-04-25 0001144204-16-096074
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 4.39B 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -25.26M 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -512.18M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 7.94M 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -13.49M 2023-01-01 2023-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -139.16M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -59.68M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -59.68M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap NetInvestmentIncome Net Investment Income USD 248.09M 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap NoncashOrPartNoncashAcquisitionInterestAcquired1 Noncash or Part Noncash Acquisition, Interest Acquired pure 0.129 2016-09-29 2016-10-01 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap NoncontrollingInterestIncreaseFromBusinessCombination Noncontrolling Interest, Increase from Business Combination USD 20.48M 2010-01-01 2010-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap NoncurrentAssets Long-Lived Assets USD 778.67M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OperatingExpenses Operating Expenses USD 752.11M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -490.13M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.63M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 948,000 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 10.76M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.12M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 8.64M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.02M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 10.44M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 9.98M 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 427,000 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 793,000 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 793,000 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 793,000 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 793,000 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 6.38M 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 10,000 2020-12-31 2020 FY 20-F 2021-04-22 0001564590-21-020156
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 793,000 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.042 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 18.28M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD 3.64M 2011-01-01 2011-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 6.73M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 273.97M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 280.70M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) USD 3.24M 2011-01-01 2011-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest USD -107.75M 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -106.78M 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD 0 2015-01-01 2015-12-31 2015 FY 20-F 2016-04-25 0001144204-16-096074
us-gaap OtherInventoryNetOfReserves Other Inventory, Net of Reserves USD 3.08M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 24,000 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap OtherLongTermDebtNoncurrent Other Long-term Debt, Noncurrent USD 4.84M 2010-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 73,000 2015-01-01 2015-12-31 2015 FY 20-F 2016-04-25 0001144204-16-096074
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 208.60M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 467,183 2011-01-01 2011-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 335,831 2009-01-01 2009-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap PaymentsOfDividends Payments of Dividends USD 3.53B 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap PaymentsOfDividendsCommonStock Payments of Ordinary Dividends, Common Stock USD 3.30B 2025-05-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap PaymentsOfDividendsMinorityInterest Payments of Ordinary Dividends, Noncontrolling Interest USD 802,000 2012-01-01 2012-12-31 2014 FY 20-F 2015-04-29 0001104659-15-031226
us-gaap PaymentsToAcquireAssetsInvestingActivities Payments to Acquire Assets, Investing Activities USD 144.54M 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 14.15M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap PaymentsToAcquireEquitySecuritiesFvNi PaymentsToAcquireEquitySecuritiesFvNi USD 4.75M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 203,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 1.48M 2010-01-01 2010-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap PaymentsToAcquireLeaseReceivables Payments to Acquire Lease Receivables USD 235,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 6.22B 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 0 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 48.92M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 8.83B 2021-01-01 2021-12-31 2021 FY 20-F 2022-04-29 0001564590-22-016857
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 0 2023-01-01 2023-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 50.00M 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2023-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 17.60M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 24,000 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses CNY 11.00M 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates Proceeds from Divestiture of Businesses and Interests in Affiliates USD 861,000 2016-01-01 2016-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries Proceeds from Divestiture of Interest in Consolidated Subsidiaries USD 181,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 318.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 16.79M 2012-01-01 2012-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit CNY 9.90M 2016-08-01 2016-08-30 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 6.57B 2021-01-01 2021-12-31 2021 FY 20-F 2022-04-29 0001564590-22-016857
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 3.19M 2012-01-01 2012-12-31 2014 FY 20-F 2015-04-29 0001104659-15-031226
us-gaap ProceedsFromPaymentsToMinorityShareholders Proceeds from (Payments to) Noncontrolling Interests USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 0 2024-01-01 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap ProceedsFromRepaymentOfLoansToPurchaseCommonStock Proceeds from Repayment of Loans to Purchase Common Stock USD 3.40M 2011-01-01 2011-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 10.67B 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 2.17B 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 409,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 3,000 2018-01-01 2018-12-31 2020 FY 20-F 2021-04-22 0001564590-21-020156
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -198.84M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.57B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 706.06M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 4.14M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 3.52M 2022-01-01 2022-12-31 2022 FY 20-F 2023-05-01 0000950170-23-015997
us-gaap RepaymentsOfDebt Repayments of Debt USD 218.76M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 1.37M 2016-07-01 2016-07-27 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 4.76M 2012-01-01 2012-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable CNY 9.50M 2016-07-01 2016-07-27 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 216.18M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 668.18M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 2.82B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap RetainedEarningsAppropriated Retained Earnings, Appropriated USD 1.59B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap RetainedEarningsUnappropriated Retained Earnings, Unappropriated USD -6.38M 2014-12-31 2014 FY 20-F 2015-04-29 0001104659-15-031226
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 386.01M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 141,000 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap RoyaltyExpense Royalty Expense USD 15,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap SalesAndExciseTaxPayableCurrent Sales and Excise Tax Payable, Current USD 904,000 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 174.35M 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 56.84M 2011-01-01 2011-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 332.98M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 0 2024-01-01 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 10,000 2020-01-01 2020-12-31 2020 FY 20-F 2021-04-22 0001564590-21-020156
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 8.25 2020-01-01 2020-12-31 2020 FY 20-F 2021-04-22 0001564590-21-020156
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 2.00M 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 8.25 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 1.96M 2020-12-31 2021 FY 20-F 2022-04-29 0001564590-22-016857
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 8.25 2021-12-31 2021 FY 20-F 2022-04-29 0001564590-22-016857
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 1.96M 2021-01-01 2021-12-31 2021 FY 20-F 2022-04-29 0001564590-22-016857
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 8.25 2021-01-01 2021-12-31 2021 FY 20-F 2022-04-29 0001564590-22-016857
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 2.37 2018-01-30 2018 FY 20-F 2019-04-29 0001564590-19-013766
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 0 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 202.34M 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 36,700 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 0 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 0 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 0 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) USD 631,395 2012-01-01 2012-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 199,000 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationNumberOfEmployeesAffected Share-based Payment Arrangement, Plan Modification, Number of Grantees Affected pure 80 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 4.98 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 4.98 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 4.98 2022-12-31 2022 FY 20-F 2023-05-01 0000950170-23-015997
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 172,500 2022-12-31 2022 FY 20-F 2023-05-01 0000950170-23-015997
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 172,500 2022-12-31 2022 FY 20-F 2023-05-01 0000950170-23-015997
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 4.98 2022-12-31 2022 FY 20-F 2023-05-01 0000950170-23-015997
us-gaap SharePrice Share Price USD/shares 5.75 2010-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap ShippingHandlingAndTransportationCosts Shipping, Handling and Transportation Costs (Deprecated 2018-01-31) USD 5.76M 2017-01-01 2017-12-31 2017 FY 20-F 2018-05-11 0001144204-18-027303
us-gaap ShortTermBankLoansAndNotesPayable Short-term Bank Loans and Notes Payable USD 229.37M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ShortTermDebtWeightedAverageInterestRate Short-term Debt, Weighted Average Interest Rate, at Point in Time pure 0.024 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ShortTermInvestments Short-term Investments USD 5.48B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 1.49M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ShortTermLeasePayments Short-term Lease Payments USD 287,000 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit USD 208,000 2013-12-31 2014 FY 20-F 2015-04-29 0001104659-15-031226
us-gaap SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeLowerBound Significant (Increase) Decrease in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Lower Bound (Deprecated 2015-01-31) USD 0 2014-12-31 2014 FY 20-F 2015-04-29 0001104659-15-031226
us-gaap SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeUpperBound Significant (Increase) Decrease in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound (Deprecated 2015-01-31) USD -361,000 2014-12-31 2014 FY 20-F 2015-04-29 0001104659-15-031226
us-gaap StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance Statutory Accounting Practices, Statutory Capital and Surplus, Balance USD 1.59B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 4.44B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 6.40B 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD 0 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 11.50M 2010-01-01 2010-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 2.00M 2018-03-07 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 135,800 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 0 2019-01-01 2019-12-31 2021 FY 20-F 2022-04-29 0001564590-22-016857
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 0 2020-01-01 2020-12-31 2022 FY 20-F 2023-05-01 0000950170-23-015997
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 85.30M 2018-01-01 2018-12-31 2020 FY 20-F 2021-04-22 0001564590-21-020156
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 676,000 2023-01-01 2023-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 335,831 2009-01-01 2009-12-31 2011 FY 20-F 2012-04-12 0001104659-12-024859
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 2.98M 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 6.73M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 0 2024-01-01 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2013-01-01 2013-12-31 2014 FY 20-F 2015-04-29 0001104659-15-031226
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense Unrecognized Tax Benefits, Income Tax Penalties Expense USD 0 2016-01-01 2016-12-31 2016 FY 20-F 2017-11-22 0001144204-17-060660
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 0 2024-01-01 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2024-01-01 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued Unrecognized Tax Benefits, Interest on Income Taxes Accrued USD 0 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense Unrecognized Tax Benefits, Interest on Income Taxes Expense USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 0 2024-01-01 2024-12-31 2024 FY 20-F 2026-04-30 0001193125-26-194394
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 83.70M 2022-01-01 2022-12-31 2023 FY 20-F 2024-04-29 0000950170-24-049936
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 71.86M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 54.93M 2012-01-01 2012-12-31 2012 FY 20-F/A 2013-05-23 0001104659-13-044076
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 71.86M 2025-01-01 2025-12-31 2025 FY 20-F 2026-06-05 0001193125-26-258534

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →